Quick Comparison

Rhodiola RoseaTianeptine
Half-Life6-8 hours (salidroside)2.5-3 hours (tianeptine), 7-8 hours (active metabolite MC5)
Typical DosageStandard: 200-400 mg daily of extract standardized to 3% rosavins and 1% salidroside. SHR-5 is the most studied extract. Take in the morning — can be mildly stimulating.Prescription dose: 12.5 mg three times daily (Stablon). Extended-release: 25 mg once daily (Tianeurax). Do not exceed prescribed doses — abuse potential at higher doses due to opioid activity.
AdministrationOral (capsules, tablets, tincture). Standardized extracts preferred.Oral (tablets). Immediate-release (12.5 mg TID) or extended-release (25 mg QD).
Research Papers10 papers10 papers
Categories

Mechanism of Action

Rhodiola Rosea

Rhodiola modulates the hypothalamic-pituitary-adrenal (HPA) axis and reduces cortisol release under stress, possibly through modulation of glucocorticoid receptor sensitivity. Salidroside and rosavins inhibit catechol-O-methyltransferase (COMT) and monoamine oxidase A and B (MAO-A, MAO-B), slowing the breakdown of dopamine, serotonin, and norepinephrine in the brain — increasing catecholamine availability in the prefrontal cortex and limbic system during stress. Rhodiola activates AMP-activated protein kinase (AMPK), a cellular energy sensor that enhances glucose uptake and mitochondrial biogenesis. It has antioxidant effects via activation of Nrf2 and HO-1, protecting neurons from stress-induced oxidative damage. Salidroside may also modulate opioid peptide (beta-endorphin) release and enhance nitric oxide production.

Tianeptine

Tianeptine is a full agonist at mu-opioid (MOR) and delta-opioid (DOR) receptors, mediating both its antidepressant/anxiolytic effects and abuse potential at high doses. Paradoxically, it enhances serotonin reuptake via SERT—opposite to SSRIs—yet still produces antidepressant effects, possibly through opioid-mediated mood regulation. Tianeptine modulates glutamatergic signaling by reversing stress-induced downregulation of AMPA receptor subunits (GluA1/GluA2) and restoring synaptic plasticity. In the hippocampus and amygdala, it prevents stress-induced dendritic atrophy, spine loss, and CA3 pyramidal cell damage—likely through opioid receptor activation and downstream HPA axis effects. It increases BDNF levels and promotes neurogenesis. The combination of opioid agonism, glutamate normalization, and neuroplasticity enhancement underlies its unique profile.

Risks & Safety

Rhodiola Rosea

Common

Mild dizziness, dry mouth, jitteriness.

Serious

May have MAOI-like properties at high doses — avoid combining with MAOI medications.

Rare

Insomnia, vivid dreams, agitation.

Tianeptine

Common

Nausea, constipation, abdominal pain, headache, dizziness, dry mouth.

Serious

Opioid-like effects at high doses (euphoria, dependence, respiratory depression). Withdrawal syndrome with abrupt cessation after chronic high-dose use. Abuse and overdose deaths reported.

Rare

Hepatotoxicity, skin reactions.

Full Profiles